<- Go Home

ImpediMed Limited

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

Market Cap

AUD 119.4M

Volume

3.0M

Cash and Equivalents

AUD 36.9M

EBITDA

-AUD 22.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

AUD 9.1M

Profit Margin

86.95%

52 Week High

AUD 0.21

52 Week Low

AUD 0.06

Dividend

N/A

Price / Book Value

2.34

Price / Earnings

-5.78

Price / Tangible Book Value

3.35

Enterprise Value

AUD 83.7M

Enterprise Value / EBITDA

-3.66

Operating Income

-AUD 23.6M

Return on Equity

42.36%

Return on Assets

-27.58

Cash and Short Term Investments

AUD 36.9M

Debt

AUD 1.3M

Equity

AUD 51.0M

Revenue

AUD 10.5M

Unlevered FCF

-AUD 14.6M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches